Contact us  Chinese
Shanghai Newsummit Biopharma Co.Ltd
business solutions
core business

Core Business Model

Key Products

core competitive advantages

Core Competitive Advantages
& Industry Status

Newsummit CRO Service Network


Taizhou Newsummit Biopharma’s status of High & New Tech Enterprise in Jiangsu Province was publicly announced

On September 5th, 2014, the Management Coordination Group of High & New Tech Enterprises in Jiangsu Province released the notification to publicize the second batch of new and high-tech enterprises in Jiangsu Province in 2014, including 1,138 organizations. The public announcement remained visible for 15 working days since September 5th, 2014. Taizhou Newsummit Biopharma Co.,Ltd. was on the list as the only bidder in China Medical City this year. After the expiry of the publicity period, Taizhou Newsummit Biopharma definitively gained official identification.

Having been subject to specific attention and guidance from Newsummit Group leaders, the recognition of High and New Tech Enterprise in Jiangsu Province was successful mainly due to close collaboration between departments within Taizhou Newsummit Biopharma and is the result of two months’ preparation and organization. It was also the recognition of hard work. After being officially identified, Taizhou Newsummit Biopharma will enjoy a 10% preferential tax status, thus positively impacting company profits.

Copyright(C)2016,Shanghai Newsummit Biopharma Co.Ltd All Rights Reserved.  Supported by Information Center